Guardant Health to Participate in Upcoming Investor Conferences

Audio By Carbonatix

PALO ALTO, Calif.--(BUSINESS WIRE)--Nov 7, 2025--

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.

• Jefferies Global Healthcare Conference in London, UK
  Fireside chat on Wednesday, November 19 at 9:30 a.m. Greenwich Mean Time
  

• Piper Sandler 37 th Annual Healthcare Conference in New York, NY
  Fireside chat on Tuesday, December 2 at 8:30 a.m. Eastern Time

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

Source: Guardant Health, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251106513309/en/

CONTACT: Investor Contact:

Zarak Khurshid

[email protected] Contact:

Meaghan Smith

[email protected]

KEYWORD: CALIFORNIA NEW YORK EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Guardant Health, Inc.

Copyright Business Wire 2025.

PUB: 11/07/2025 08:00 AM/DISC: 11/07/2025 08:01 AM

http://www.businesswire.com/news/home/20251106513309/en